The Trump administration initiative to advance government-funded ibogaine research follows calls from veterans and experts for strict safety standards on psychedelic treatments.

Mind-altering substances like psilocybin, LSD, MDMA, and ayahuasca and their therapeutic and cultural use.

First government-funded clinical trials of ibogaine for opioid addiction and PTSD, conducted by the FDA and VA.